Complex roles of filamin-A mediated cytoskeleton network in cancer progression

Cell and Bioscience

Volumn 3, Issue 1, 2013, Pages

  Yue, Jingyin ^a,b   Huhn, Steven ^a   Shen, Zhiyuan ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

ABP 280; Actin filament; Cytoskeleton; DNA repair; Filamin A; Metastasis

Indexed keywords

EID: 84873647052     PISSN: None     EISSN: 20453701     Source Type: Journal    
DOI: 10.1186/2045-3701-3-7     Document Type: Review

References (140)

1. Wickstead B, Gull K. The evolution of the cytoskeleton. J Cell Biol 2012, 194(4):513-525.
2. Doherty GJ, McMahon HT. Mediation, modulation, and consequences of membrane-cytoskeleton interactions. Annu Rev Biophys 2008, 37:65-95. 10.1146/annurev.biophys.37.032807.125912, 18573073.
3. Boggiano JC, Fehon RG. Growth control by committee: intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling. Dev Cell 2012, 22(4):695-702. 10.1016/j.devcel.2012.03.013, 22516196.
4. Galkin VE, Orlova A, Egelman EH. Actin filaments as tension sensors. Curr Biol 2012, 22(3):R96-R101. 10.1016/j.cub.2011.12.010, 3277726, 22321312.
5. Dominguez R, Holmes KC. Actin structure and function. Annu Rev Biophys 2011, 40:169-186. 10.1146/annurev-biophys-042910-155359, 3130349, 21314430.
6. Otto JJ. Actin-bundling proteins. Curr Opin Cell Biol 1994, 6(1):105-109. 10.1016/0955-0674(94)90123-6, 8167015.
7. Van Troys M, Vandekerckhove J, Ampe C. Structural modules in actin-binding proteins: towards a new classification. Biochim Biophys Acta 1999, 1448(3):323-348. 10.1016/S0167-4889(98)00152-9, 9990286.
8. Matsudaira P. Modular organization of actin crosslinking proteins. Trends Biochem Sci 1991, 16(3):87-92.
9. Low SH, Mukhina S, Srinivas V, Ng CZ, Murata-Hori M. Domain analysis of alpha-actinin reveals new aspects of its association with F-actin during cytokinesis. Exp Cell Res 2010, 316(12):1925-1934. 10.1016/j.yexcr.2010.03.004, 20230817.
10. Zhou AX, Hartwig JH, Akyurek LM. Filamins in cell signaling, transcription and organ development. Trends Cell Biol 2010, 20(2):113-123. 10.1016/j.tcb.2009.12.001, 20061151.
11. van der Flier A, Sonnenberg A. Structural and functional aspects of filamins. Biochim Biophys Acta 2001, 1538(2-3):99-117.
12. Wang K. Filamin, a new high-molecular-weight protein found in smooth muscle and nonmuscle cells. Purification and properties of chicken gizzard filamin. Biochemistry 1977, 16(9):1857-1865. 10.1021/bi00628a015, 139917.
13. Wang K, Ash JF, Singer SJ. Filamin, a new high-molecular-weight protein found in smooth muscle and non-muscle cells. Proc Natl Acad Sci USA 1975, 72(11):4483-4486. 10.1073/pnas.72.11.4483, 388746, 53835.
14. Gorlin JB, Yamin R, Egan S, Stewart M, Stossel TP, Kwiatkowski DJ, Hartwig JH. Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring. J Cell Biol 1990, 111(3):1089-1105. 10.1083/jcb.111.3.1089, 2116286, 2391361.
15. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M, Shapiro SS. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol 2001, 2(2):138-145. 10.1038/35052082, 11252955.
16. Cunningham CC, Gorlin JB, Kwiatkowski DJ, Hartwig JH, Janmey PA, Byers HR, Stossel TP. Actin-binding protein requirement for cortical stability and efficient locomotion. Science 1992, 255(5042):325-327. 10.1126/science.1549777, 1549777.
17. Ohta Y, Hartwig JH, Stossel TP. FilGAP, a Rho- and ROCK-regulated GAP for Rac binds filamin A to control actin remodelling. Nat Cell Biol 2006, 8(8):803-814. 10.1038/ncb1437, 16862148.
18. Popowicz GM, Schleicher M, Noegel AA, Holak TA. Filamins: promiscuous organizers of the cytoskeleton. Trends Biochem Sci 2006, 31(7):411-419. 10.1016/j.tibs.2006.05.006, 16781869.
19. Feng Y, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol 2004, 6(11):1034-1038. 10.1038/ncb1104-1034, 15516996.
20. Sheen VL, Dixon PH, Fox JW, Hong SE, Kinton L, Sisodiya SM, Duncan JS, Dubeau F, Scheffer IE, Schachter SC, et al. Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet 2001, 10(17):1775-1783. 10.1093/hmg/10.17.1775, 11532987.
21. Fox JW, Lamperti ED, Eksioglu YZ, Hong SE, Feng Y, Graham DA, Scheffer IE, Dobyns WB, Hirsch BA, Radtke RA, et al. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 1998, 21(6):1315-1325. 10.1016/S0896-6273(00)80651-0, 9883725.
22. Chardon JW, Mignot C, Aradhya S, Keren B, Afenjar A, Kaminska A, Beldjord C, Heron D, Boycott KM. Deletion of filamin A in two female patients with periventricular nodular heterotopia. Am J Med Genet A 2012, 158A(6):1512-1516. 10.1002/ajmg.a.35409, 22522697.
23. Moro F, Carrozzo R, Veggiotti P, Tortorella G, Toniolo D, Volzone A, Guerrini R. Familial periventricular heterotopia: missense and distal truncating mutations of the FLN1 gene. Neurology 2002, 58(6):916-921. 10.1212/WNL.58.6.916, 11914408.
24. Dobyns WB, Andermann E, Andermann F, Czapansky-Beilman D, Dubeau F, Dulac O, Guerrini R, Hirsch B, Ledbetter DH, Lee NS, et al. X-linked malformations of neuronal migration. Neurology 1996, 47(2):331-339. 10.1212/WNL.47.2.331, 8757001.
25. Ferland RJ, Batiz LF, Neal J, Lian G, Bundock E, Lu J, Hsiao YC, Diamond R, Mei D, Banham AH, et al. Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia. Hum Mol Genet 2009, 18(3):497-516. 2722192, 18996916.
26. Cardoso C, Boys A, Parrini E, Mignon-Ravix C, McMahon JM, Khantane S, Bertini E, Pallesi E, Missirian C, Zuffardi O, et al. Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion. Neurology 2009, 72(9):784-792. 10.1212/01.wnl.0000336339.08878.2d, 19073947.
27. Ferland RJ, Gaitanis JN, Apse K, Tantravahi U, Walsh CA, Sheen VL. Periventricular nodular heterotopia and Williams syndrome. Am J Med Genet A 2006, 140(12):1305-1311.
28. Sheen VL, Ganesh VS, Topcu M, Sebire G, Bodell A, Hill RS, Grant PE, Shugart YY, Imitola J, Khoury SJ, et al. Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. Nat Genet 2004, 36(1):69-76. 10.1038/ng1276, 14647276.
29. Sheen VL, Wheless JW, Bodell A, Braverman E, Cotter PD, Rauen KA, Glenn O, Weisiger K, Packman S, Walsh CA, et al. Periventricular heterotopia associated with chromosome 5p anomalies. Neurology 2003, 60(6):1033-1036. 10.1212/01.WNL.0000052689.03214.61, 12654978.
30. Parrini E, Ramazzotti A, Dobyns WB, Mei D, Moro F, Veggiotti P, Marini C, Brilstra EH, Dalla Bernardina B, Goodwin L, et al. Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations. Brain 2006, 129(Pt 7):1892-1906.
31. Jefferies JL, Taylor MD, Rossano J, Belmont JW, Craigen WJ. Novel cardiac findings in periventricular nodular heterotopia. Am J Med Genet A 2010, 152A(1):165-168. 10.1002/ajmg.a.33110, 20014127.
32. Sheen VL, Jansen A, Chen MH, Parrini E, Morgan T, Ravenscroft R, Ganesh V, Underwood T, Wiley J, Leventer R, et al. Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome. Neurology 2005, 64(2):254-262. 10.1212/01.WNL.0000149512.79621.DF, 15668422.
33. de Wit MC, de Coo IF, Lequin MH, Halley DJ, Roos-Hesselink JW, Mancini GM. Combined cardiological and neurological abnormalities due to filamin A gene mutation. Clin Res Cardiol 2011, 100(1):45-50. 10.1007/s00392-010-0206-y, 3022162, 20730588.
34. Kakita A, Hayashi S, Moro F, Guerrini R, Ozawa T, Ono K, Kameyama S, Walsh CA, Takahashi H. Bilateral periventricular nodular heterotopia due to filamin 1 gene mutation: widespread glomeruloid microvascular anomaly and dysplastic cytoarchitecture in the cerebral cortex. Acta Neuropathol 2002, 104(6):649-657.
35. Sheen VL, Walsh CA. Periventricular heterotopia: new insights into Ehlers-Danlos syndrome. Clin Med Res 2005, 3(4):229-233. 10.3121/cmr.3.4.229, 1288408, 16303888.
36. Robertson SP, Twigg SR, Sutherland-Smith AJ, Biancalana V, Gorlin RJ, Horn D, Kenwrick SJ, Kim CA, Morava E, Newbury-Ecob R, et al. Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. Nat Genet 2003, 33(4):487-491. 10.1038/ng1119, 12612583.
37. Kyndt F, Gueffet JP, Probst V, Jaafar P, Legendre A, Le Bouffant F, Toquet C, Roy E, McGregor L, Lynch SA, et al. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation 2007, 115(1):40-49.
38. Bernstein JA, Bernstein D, Hehr U, Hudgins L. Familial cardiac valvulopathy due to filamin A mutation. Am J Med Genet A 2011, 155A(9):2236-2241.
39. Feng Y, Chen MH, Moskowitz IP, Mendonza AM, Vidali L, Nakamura F, Kwiatkowski DJ, Walsh CA. Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis. Proc Natl Acad Sci USA 2006, 103(52):19836-19841. 10.1073/pnas.0609628104, 1702530, 17172441.
40. Hart AW, Morgan JE, Schneider J, West K, McKie L, Bhattacharya S, Jackson IJ, Cross SH. Cardiac malformations and midline skeletal defects in mice lacking filamin A. Hum Mol Genet 2006, 15(16):2457-2467. 10.1093/hmg/ddl168, 16825286.
41. Leung R, Wang Y, Cuddy K, Sun C, Magalhaes J, Grynpas M, Glogauer M. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis. J Bone Miner Res 2010, 25(5):1077-1091.
42. Lian G, Lu J, Hu J, Zhang J, Cross SH, Ferland RJ, Sheen VL. Filamin a regulates neural progenitor proliferation and cortical size through Wee1-dependent Cdk1 phosphorylation. J Neurosci 2012, 32(22):7672-7684. 10.1523/JNEUROSCI.0894-12.2012, 3368379, 22649246.
43. Lynch CD, Gauthier NC, Biais N, Lazar AM, Roca-Cusachs P, Yu CH, Sheetz MP. Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions. Mol Biol Cell 2011, 22(8):1263-1273. 10.1091/mbc.E10-08-0661, 3198308, 21325628.
44. Gardel ML, Nakamura F, Hartwig JH, Crocker JC, Stossel TP, Weitz DA. Prestressed F-actin networks cross-linked by hinged filamins replicate mechanical properties of cells. Proc Natl Acad Sci USA 2006, 103(6):1762-1767. 10.1073/pnas.0504777103, 1413620, 16446458.
45. Kasza KE, Nakamura F, Hu S, Kollmannsberger P, Bonakdar N, Fabry B, Stossel TP, Wang N, Weitz DA. Filamin A is essential for active cell stiffening but not passive stiffening under external force. Biophys J 2009, 96(10):4326-4335. 10.1016/j.bpj.2009.02.035, 2712146, 19450503.
46. Glogauer M, Arora P, Chou D, Janmey PA, Downey GP, McCulloch CA. The role of actin-binding protein 280 in integrin-dependent mechanoprotection. J Biol Chem 1998, 273(3):1689-1698. 10.1074/jbc.273.3.1689, 9430714.
47. Nakamura F, Osborn TM, Hartemink CA, Hartwig JH, Stossel TP. Structural basis of filamin A functions. J Cell Biol 2007, 179(5):1011-1025. 10.1083/jcb.200707073, 2099194, 18056414.
48. Ithychanda SS, Qin J. Evidence for multisite ligand binding and stretching of filamin by integrin and migfilin. Biochemistry 2011, 50(20):4229-4231. 10.1021/bi2003229, 3097901, 21524097.
49. Pentikainen U, Ylanne J. The regulation mechanism for the auto-inhibition of binding of human filamin A to integrin. J Mol Biol 2009, 393(3):644-657. 10.1016/j.jmb.2009.08.035, 19699211.
50. Lad Y, Kiema T, Jiang P, Pentikainen OT, Coles CH, Campbell ID, Calderwood DA, Ylanne J. Structure of three tandem filamin domains reveals auto-inhibition of ligand binding. EMBO J 2007, 26(17):3993-4004. 10.1038/sj.emboj.7601827, 1948075, 17690686.
51. Samuelsson SJ, Luther PW, Pumplin DW, Bloch RJ. Structures linking microfilament bundles to the membrane at focal contacts. J Cell Biol 1993, 122(2):485-496. 10.1083/jcb.122.2.485, 2119644, 7686554.
52. Kim H, Nakamura F, Lee W, Hong C, Perez-Sala D, McCulloch CA. Regulation of cell adhesion to collagen via beta1 integrins is dependent on interactions of filamin A with vimentin and protein kinase C epsilon. Exp Cell Res 2010, 316(11):1829-1844. 10.1016/j.yexcr.2010.02.007, 20171211.
53. Kim H, Nakamura F, Lee W, Shifrin Y, Arora P, McCulloch CA. Filamin A is required for vimentin-mediated cell adhesion and spreading. Am J Physiol Cell Physiol 2010, 298(2):C221-C236. 10.1152/ajpcell.00323.2009, 19776392.
54. Hartwig JH, Stossel TP. Isolation and properties of actin, myosin, and a new actinbinding protein in rabbit alveolar macrophages. J Biol Chem 1975, 250(14):5696-5705.
55. Nakamura F, Hartwig JH, Stossel TP, Szymanski PT. Ca2+ and calmodulin regulate the binding of filamin A to actin filaments. J Biol Chem 2005, 280(37):32426-32433. 10.1074/jbc.M502203200, 16030015.
56. Griffiths GS, Grundl M, Allen JS, Matter ML. R-Ras interacts with filamin a to maintain endothelial barrier function. J Cell Physiol 2011, 226(9):2287-2296. 10.1002/jcp.22565, 3080452, 21660952.
57. Gawecka JE, Griffiths GS, Ek-Rylander B, Ramos JW, Matter ML. R-Ras regulates migration through an interaction with filamin A in melanoma cells. PLoS One 2010, 5(6):e11269. 10.1371/journal.pone.0011269, 2890414, 20585650.
58. Falet H, Pollitt AY, Begonja AJ, Weber SE, Duerschmied D, Wagner DD, Watson SP, Hartwig JH. A novel interaction between FlnA and Syk regulates platelet ITAM-mediated receptor signaling and function. J Exp Med 2010, 207(9):1967-1979. 10.1084/jem.20100222, 2931168, 20713593.
59. Smith TC, Fang Z, Luna EJ. Novel interactors and a role for supervillin in early cytokinesis. Cytoskeleton (Hoboken) 2010, 67(6):346-364.
60. Lin R, Karpa K, Kabbani N, Goldman-Rakic P, Levenson R. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A. Proc Natl Acad Sci USA 2001, 98(9):5258-5263. 10.1073/pnas.011538198, 33197, 11320256.
61. Kim KM, Gainetdinov RR, Laporte SA, Caron MG, Barak LS. G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation. J Biol Chem 2005, 280(13):12774-12780.
62. Li C, Yu S, Nakamura F, Pentikainen OT, Singh N, Yin S, Xin W, Sy MS. Pro-prion binds filamin A, facilitating its interaction with integrin beta1, and contributes to melanomagenesis. J Biol Chem 2010, 285(39):30328-30339. 10.1074/jbc.M110.147413, 2943319, 20650901.
63. Li C, Yu S, Nakamura F, Yin S, Xu J, Petrolla AA, Singh N, Tartakoff A, Abbott DW, Xin W, et al. Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J Clin Invest 2009, 119(9):2725-2736. 10.1172/JCI39542, 2735930, 19690385.
64. Nakamura F, Pudas R, Heikkinen O, Permi P, Kilpelainen I, Munday AD, Hartwig JH, Stossel TP, Ylanne J. The structure of the GPIb-filamin A complex. Blood 2006, 107(5):1925-1932. 10.1182/blood-2005-10-3964, 1895705, 16293600.
65. Kanaji T, Ware J, Okamura T, Newman PJ. GPIbalpha regulates platelet size by controlling the subcellular localization of filamin. Blood 2012, 119(12):2906-2913. 10.1182/blood-2011-08-376566, 22174152.
66. Kiema T, Lad Y, Jiang P, Oxley CL, Baldassarre M, Wegener KL, Campbell ID, Ylanne J, Calderwood DA. The molecular basis of filamin binding to integrins and competition with talin. Mol Cell 2006, 21(3):337-347. 10.1016/j.molcel.2006.01.011, 16455489.
67. Sharma CP, Ezzell RM, Arnaout MA. Direct interaction of filamin (ABP-280) with the beta 2-integrin subunit CD18. J Immunol 1995, 154(7):3461-3470.
68. Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 1998, 140(5):1241-1253. 10.1083/jcb.140.5.1241, 2132689, 9490735.
69. Klaile E, Muller MM, Kannicht C, Singer BB, Lucka L. CEACAM1 functionally interacts with filamin A and exerts a dual role in the regulation of cell migration. J Cell Sci 2005, 118(Pt 23):5513-5524.
70. Lad Y, Jiang P, Ruskamo S, Harburger DS, Ylanne J, Campbell ID, Calderwood DA. Structural basis of the migfilin-filamin interaction and competition with integrin beta tails. J Biol Chem 2008, 283(50):35154-35163. 10.1074/jbc.M802592200, 2596399, 18829455.
71. Ithychanda SS, Das M, Ma YQ, Ding K, Wang X, Gupta S, Wu C, Plow EF, Qin J. Migfilin, a molecular switch in regulation of integrin activation. J Biol Chem 2009, 284(7):4713-4722. 2640964, 19074766.
72. Tu Y, Wu S, Shi X, Chen K, Wu C. Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell 2003, 113(1):37-47. 10.1016/S0092-8674(03)00163-6, 12679033.
73. Stahlhut M, van Deurs B. Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol Biol Cell 2000, 11(1):325-337. 14777, 10637311.
74. Muriel O, Echarri A, Hellriegel C, Pavon DM, Beccari L, Del Pozo MA. Phosphorylated filamin A regulates actin-linked caveolae dynamics. J Cell Sci 2011, 124(Pt 16):2763-2776.
75. Scott MG, Pierotti V, Storez H, Lindberg E, Thuret A, Muntaner O, Labbe-Jullie C, Pitcher JA, Marullo S. Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins. Mol Cell Biol 2006, 26(9):3432-3445. 10.1128/MCB.26.9.3432-3445.2006, 1447405, 16611986.
76. Nallapalli RK, Ibrahim MX, Zhou AX, Bandaru S, Naresh S, Redfors B, Pazooki D, Zhang Y, Boren J, Cao Y, et al. Targeting filamin A reduces K-RAS-induced lung adenocarcinomas and endothelial response to tumor growth in mice. Mol Cancer 2012, 11(1):50. 10.1186/1476-4598-11-50, 3441416, 22857000.
77. Muscolini M, Sajeva A, Caristi S, Tuosto L. A novel association between filamin A and NF-kappaB inducing kinase couples CD28 to inhibitor of NF-kappaB kinase alpha and NF-kappaB activation. Immunol Lett 2011, 136(2):203-212. 10.1016/j.imlet.2011.01.011, 21277899.
78. Najib S, Saint-Laurent N, Esteve JP, Schulz S, Boutet-Robinet E, Fourmy D, Lattig J, Mollereau C, Pyronnet S, Susini C, et al. A switch of G protein-coupled receptor binding preference from phosphoinositide 3-kinase (PI3K)-p85 to filamin A negatively controls the PI3K pathway. Mol Cell Biol 2012, 32(5):1004-1016. 10.1128/MCB.06252-11, 3295190, 22203038.
79. Castoria G, D'Amato L, Ciociola A, Giovannelli P, Giraldi T, Sepe L, Paolella G, Barone MV, Migliaccio A, Auricchio F. Androgen-induced cell migration: role of androgen receptor/filamin A association. PLoS One 2011, 6(2):e17218. 10.1371/journal.pone.0017218, 3040221, 21359179.
80. Ozanne DM, Brady ME, Cook S, Gaughan L, Neal DE, Robson CN. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. Mol Endocrinol 2000, 14(10):1618-1626. 10.1210/me.14.10.1618, 11043577.
81. Marti A, Luo Z, Cunningham C, Ohta Y, Hartwig J, Stossel TP, Kyriakis JM, Avruch J. Actin-binding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-alpha activation of SAPK in melanoma cells. J Biol Chem 1997, 272(5):2620-2628. 10.1074/jbc.272.5.2620, 9006895.
82. Leonardi A, Ellinger-Ziegelbauer H, Franzoso G, Brown K, Siebenlist U. Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2. J Biol Chem 2000, 275(1):271-278. 10.1074/jbc.275.1.271, 10617615.
83. Ohta Y, Suzuki N, Nakamura S, Hartwig JH, Stossel TP. The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci USA 1999, 96(5):2122-2128. 10.1073/pnas.96.5.2122, 26747, 10051605.
84. Ueda K, Ohta Y, Hosoya H. The carboxy-terminal pleckstrin homology domain of ROCK interacts with filamin-A. Biochem Biophys Res Commun 2003, 301(4):886-890. 10.1016/S0006-291X(03)00048-2, 12589795.
85. Nakamura F, Heikkinen O, Pentikainen OT, Osborn TM, Kasza KE, Weitz DA, Kupiainen O, Permi P, Kilpelainen I, Ylanne J, et al. Molecular basis of filamin A-FilGAP interaction and its impairment in congenital disorders associated with filamin A mutations. PLoS One 2009, 4(3):e4928. 10.1371/journal.pone.0004928, 2654154, 19293932.
86. Bellanger JM, Astier C, Sardet C, Ohta Y, Stossel TP, Debant A. The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin. Nat Cell Biol 2000, 2(12):888-892. 10.1038/35046533, 11146652.
87. Velkova A, Carvalho MA, Johnson JO, Tavtigian SV, Monteiro AN. Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair. Cell Cycle 2010, 9(7):1421-1433. 3040726, 20305393.
88. Yue J, Wang Q, Lu H, Brenneman M, Fan F, Shen Z. The cytoskeleton protein filamin-A is required for an efficient recombinational DNA double strand break repair. Cancer Res 2009, 69(20):7978-7985. 10.1158/0008-5472.CAN-09-2177, 2763018, 19808958.
89. Yuan Y, Shen Z. Interaction with BRCA2 suggests a role for filamin-1 (hsFLNa) in DNA damage response. J Biol Chem 2001, 276(51):48318-48324.
90. Meng X, Yuan Y, Maestas A, Shen Z. Recovery from DNA damage-induced G2 arrest requires actin-binding protein filamin-A/actin-binding protein 280. J Biol Chem 2004, 279(7):6098-6105.
91. Gay O, Gilquin B, Nakamura F, Jenkins ZA, McCartney R, Krakow D, Deshiere A, Assard N, Hartwig JH, Robertson SP, et al. RefilinB (FAM101B) targets filamin A to organize perinuclear actin networks and regulates nuclear shape. Proc Natl Acad Sci USA 2011, 108(28):11464-11469. 10.1073/pnas.1104211108, 3136255, 21709252.
92. Deng W, Lopez-Camacho C, Tang JY, Mendoza-Villanueva D, Maya-Mendoza A, Jackson DA, Shore P. Cytoskeletal protein filamin A is a nucleolar protein that suppresses ribosomal RNA gene transcription. Proc Natl Acad Sci USA 2012, 109(5):1524-1529. 10.1073/pnas.1107879109, 3277164, 22307607.
93. Qiu H, Nomiyama R, Moriguchi K, Fukada T, Sugimoto K. Identification of novel nuclear protein interactions with the N-terminal part of filamin A. Biosci Biotechnol Biochem 2011, 75(1):145-147. 10.1271/bbb.100567, 21228480.
94. Flanagan LA, Chou J, Falet H, Neujahr R, Hartwig JH, Stossel TP. Filamin A, the Arp2/3 complex, and the morphology and function of cortical actin filaments in human melanoma cells. J Cell Biol 2001, 155(4):511-517. 10.1083/jcb.200105148, 2198874, 11706047.
95. Nakamura F, Osborn E, Janmey PA, Stossel TP. Comparison of filamin A-induced cross-linking and Arp2/3 complex-mediated branching on the mechanics of actin filaments. J Biol Chem 2002, 277(11):9148-9154. 10.1074/jbc.M111297200, 11786548.
96. Ulrich F, Heisenberg CP. Trafficking and cell migration. Traffic 2009, 10(7):811-818. 10.1111/j.1600-0854.2009.00929.x, 19490534.
97. Pellinen T, Ivaska J. Integrin traffic. J Cell Sci 2006, 119(Pt 18):3723-3731.
98. D'Addario M, Arora PD, Fan J, Ganss B, Ellen RP, McCulloch CA. Cytoprotection against mechanical forces delivered through beta 1 integrins requires induction of filamin A. J Biol Chem 2001, 276(34):31969-31977. 10.1074/jbc.M102715200, 11423540.
99. Meyer SC, Sanan DA, Fox JE. Role of actin-binding protein in insertion of adhesion receptors into the membrane. J Biol Chem 1998, 273(5):3013-3020. 10.1074/jbc.273.5.3013, 9446615.
100. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci 2010, 123(Pt 24):4195-4200. 2995612, 21123617.
101. Larsen M, Artym VV, Green JA, Yamada KM. The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol 2006, 18(5):463-471. 10.1016/j.ceb.2006.08.009, 16919434.
102. Xian X, Gopal S, Couchman JR. Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res 2010, 339(1):31-46. 10.1007/s00441-009-0829-3, 19597846.
103. Harburger DS, Calderwood DA. Integrin signalling at a glance. J Cell Sci 2009, 122(Pt 2):159-163. 2714413, 19118207.
104. Leitinger B, Hohenester E. Mammalian collagen receptors. Matrix Biol 2007, 26(3):146-155. 10.1016/j.matbio.2006.10.007, 17141492.
105. Calderwood DA, Huttenlocher A, Kiosses WB, Rose DM, Woodside DG, Schwartz MA, Ginsberg MH. Increased filamin binding to beta-integrin cytoplasmic domains inhibits cell migration. Nat Cell Biol 2001, 3(12):1060-1068. 10.1038/ncb1201-1060, 11781567.
106. Xu Y, Bismar TA, Su J, Xu B, Kristiansen G, Varga Z, Teng L, Ingber DE, Mammoto A, Kumar R, et al. Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. J Exp Med 2010, 207(11):2421-2437. 10.1084/jem.20100433, 2964581, 20937704.
107. Zhu TN, He HJ, Kole S, D'Souza T, Agarwal R, Morin PJ, Bernier M. Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells. J Biol Chem 2007, 282(20):14816-14826. 10.1074/jbc.M611430200, 17389601.
108. Baldassarre M, Razinia Z, Brahme N, Buccione R, Calderwood DA. Filamin A controls matrix metalloprotease activity and regulates cell invasion in human fibrosarcoma cells. J Cell Sci 2012, 2012:17.
109. Byfield FJ, Wen Q, Levental I, Nordstrom K, Arratia PE, Miller RT, Janmey PA. Absence of filamin A prevents cells from responding to stiffness gradients on gels coated with collagen but not fibronectin. Biophys J 2009, 96(12):5095-5102. 10.1016/j.bpj.2009.03.046, 2712047, 19527669.
110. Kim H, Sengupta A, Glogauer M, McCulloch CA. Filamin A regulates cell spreading and survival via beta1 integrins. Exp Cell Res 2008, 314(4):834-846. 10.1016/j.yexcr.2007.11.022, 18177638.
111. Adams M, Simms RJ, Abdelhamed Z, Dawe HR, Szymanska K, Logan CV, Wheway G, Pitt E, Gull K, Knowles MA, et al. A meckelin-filamin A interaction mediates ciliogenesis. Hum Mol Genet 2012, 21(6):1272-1286. 10.1093/hmg/ddr557, 22121117.
112. Ai J, Huang H, Lv X, Tang Z, Chen M, Chen T, Duan W, Sun H, Li Q, Tan R, et al. FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol Biochem 2011, 27(3-4):207-216.
113. Alper O, Stetler-Stevenson WG, Harris LN, Leitner WW, Ozdemirli M, Hartmann D, Raffeld M, Abu-Asab M, Byers S, Zhuang Z, et al. Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma. Cancer Sci 2009, 100(9):1748-1756. 10.1111/j.1349-7006.2009.01244.x, 2788299, 19594548.
114. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, et al. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res 2009, 15(3):788-796. 10.1158/1078-0432.CCR-08-1402, 2666194, 19188148.
115. Carabalona A, Beguin S, Pallesi-Pocachard E, Buhler E, Pellegrino C, Arnaud K, Hubert P, Oualha M, Siffroi JP, Khantane S, et al. A glial origin for periventricular nodular heterotopia caused by impaired expression of Filamin-A. Hum Mol Genet 2012, 21(5):1004-1017. 10.1093/hmg/ddr531, 22076441.
116. Xi J, Yue J, Lu H, Campbell N, Yang Q, Lan S, Haffty BG, Yuan C, Shen Z. Inhibition of Filamin-A Reduces Cancer Metastatic Potential. Int J Biol Sci 2013, 9(1):67-77. 10.7150/ijbs.5577, 3535535, 23289018.
117. Baldassarre M, Razinia Z, Burande CF, Lamsoul I, Lutz PG, Calderwood DA. Filamins regulate cell spreading and initiation of cell migration. PLoS One 2009, 4(11):e7830. 10.1371/journal.pone.0007830, 2773003, 19915675.
118. Heuze ML, Lamsoul I, Baldassarre M, Lad Y, Leveque S, Razinia Z, Moog-Lutz C, Calderwood DA, Lutz PG. ASB2 targets filamins A and B to proteasomal degradation. Blood 2008, 112(13):5130-5140. 10.1182/blood-2007-12-128744, 2597609, 18799729.
119. Razinia Z, Baldassarre M, Bouaouina M, Lamsoul I, Lutz PG, Calderwood DA. The E3 ubiquitin ligase specificity subunit ASB2alpha targets filamins for proteasomal degradation by interacting with the filamin actin-binding domain. J Cell Sci 2011, 124(Pt 15):2631-2641. 3138704, 21750192.
120. O'Connell MP, Fiori JL, Baugher KM, Indig FE, French AD, Camilli TC, Frank BP, Earley R, Hoek KS, Hasskamp JH, et al. Wnt5A activates the calpain-mediated cleavage of filamin A. J Invest Dermatol 2009, 129(7):1782-1789. 10.1038/jid.2008.433, 2695838, 19177143.
121. Guiet R, Verollet C, Lamsoul I, Cougoule C, Poincloux R, Labrousse A, Calderwood DA, Glogauer M, Lutz PG, Maridonneau-Parini I. Macrophage mesenchymal migration requires podosome stabilization by filamin A. J Biol Chem 2012, 287(16):13051-13062. 10.1074/jbc.M111.307124, 22334688.
122. De Braekeleer M, Morel F, Le Bris MJ, Herry A, Douet-Guilbert N. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia. Anticancer Res 2005, 25(3B):1931-1944.
123. De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris MJ, Meyer C, Marschalek R, Ferec C, De Braekeleer M. FLNA, a new partner gene fused to MLL in a patient with acute myelomonoblastic leukaemia. Br J Haematol 2009, 146(6):693-695. 10.1111/j.1365-2141.2009.07824.x, 19622092.
124. Fiori JL, Zhu TN, O'Connell MP, Hoek KS, Indig FE, Frank BP, Morris C, Kole S, Hasskamp J, Elias G, et al. Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells. Endocrinology 2009, 150(6):2551-2560. 10.1210/en.2008-1344, 2689793, 19213840.
125. Byers HR, Etoh T, Doherty JR, Sober AJ, Mihm MC. Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am J Pathol 1991, 139(2):423-435. 1886079, 1867326.
126. Yue J, Lan S, Yuan C, Shen Z. Prognostic values of filamin-A status for topoisomerase II poison chemotherapy. Int J Biol Sci 2012, 8(4):442-450. 10.7150/ijbs.4155, 3303170, 22419889.
127. Yue J, Lu H, Liu J, Berwick M, Shen Z. Filamin-A as a marker and target for DNA damage based cancer therapy. DNA Repair (Amst) 2012, 11(2):192-200.
128. Shen Z. Genomic instability and cancer: an introduction. J Mol Cell Biol 2011, 3(1):1-3. 10.1093/jmcb/mjq057, 21278445.
129. Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005, 4(12):1920-1932. 10.1074/mcp.M500279-MCP200, 16127175.
130. Frierson HF, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, Saku T, Moskaluk CA, Hampton GM. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 2002, 161(4):1315-1323. 10.1016/S0002-9440(10)64408-2, 1867312, 12368205.
131. Guedj N, Zhan Q, Perigny M, Rautou PE, Degos F, Belghiti J, Farges O, Bedossa P, Paradis V. Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas. J Hepatol 2009, 51(1):93-101. 10.1016/j.jhep.2009.03.017, 19446907.
132. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006, 9(4):287-300. 10.1016/j.ccr.2006.03.003, 16616334.
133. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, Kuick R, Hanash S. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003, 63(10):2649-2657.
134. Smith SC, Oxford G, Baras AS, Owens C, Havaleshko D, Brautigan DL, Safo MK, Theodorescu D. Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clin Cancer Res 2007, 13(13):3803-3813. 10.1158/1078-0432.CCR-06-2419, 17606711.
135. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 2006, 24(5):778-789. 10.1200/JCO.2005.03.2375, 16432078.
136. Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001, 61(7):3124-3130.
137. Wang HY, Bakshi K, Frankfurt M, Stucky A, Goberdhan M, Shah SM, Burns LH. Reducing amyloid-related Alzheimer's disease pathogenesis by a small molecule targeting filamin a. J Neurosci 2012, 32(29):9773-9784. 10.1523/JNEUROSCI.0354-12.2012, 22815492.
138. Wang HY, Burns LH. Naloxone's pentapeptide binding site on filamin A blocks Mu opioid receptor-Gs coupling and CREB activation of acute morphine. PLoS One 2009, 4(1):e4282. 10.1371/journal.pone.0004282, 2628740, 19172190.
139. Jay D, Garcia EJ, Lara JE, Medina MA, de la Luz IM. Determination of a cAMP-dependent protein kinase phosphorylation site in the C-terminal region of human endothelial actin-binding protein. Arch Biochem Biophys 2000, 377(1):80-84. 10.1006/abbi.2000.1762, 10775444.
140. Wang Y, Kreisberg JI, Bedolla RG, Mikhailova M, DeVere White RW, Ghosh PM. A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells. Oncogene 2007, 26(41):6061-6070. 10.1038/sj.onc.1210435, 17420725.